Skip to main content

MRI News

FDA Approves Gadavist (gadobutrol) Contrast Agent for Use in Cardiac MR in Adult Patients with Known or Suspected Coronary Artery Disease

WHIPPANY, N.J., July 15, 2019 /PRNewswire/ – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use in cardiac magnetic resonance (MR)...

Ask a question

To post your own question to this support group, sign in or create an account.